Highly reliable, targeted photothermal cancer therapy combined with thermal dosimetry using a near-infrared absorbent

Photothermal therapy (PTT) using a photo-absorbent in the near-infrared (NIR) region is an effective methodology for local cancer treatment. Before PTT using a NIR absorbent is executed, the operator generally determines the two parameters of fluence rate and irradiation time. However, even if the i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scientific reports 2020-06, Vol.10 (1), p.9765, Article 9765
Hauptverfasser: Nomura, Shinsuke, Morimoto, Yuji, Tsujimoto, Hironori, Arake, Masashi, Harada, Manabu, Saitoh, Daizoh, Hara, Isao, Ozeki, Eiichi, Satoh, Ayano, Takayama, Eiji, Hase, Kazuo, Kishi, Yoji, Ueno, Hideki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page 9765
container_title Scientific reports
container_volume 10
creator Nomura, Shinsuke
Morimoto, Yuji
Tsujimoto, Hironori
Arake, Masashi
Harada, Manabu
Saitoh, Daizoh
Hara, Isao
Ozeki, Eiichi
Satoh, Ayano
Takayama, Eiji
Hase, Kazuo
Kishi, Yoji
Ueno, Hideki
description Photothermal therapy (PTT) using a photo-absorbent in the near-infrared (NIR) region is an effective methodology for local cancer treatment. Before PTT using a NIR absorbent is executed, the operator generally determines the two parameters of fluence rate and irradiation time. However, even if the irradiation parameters are unchanged, the therapeutic effect of PTT is often different for individual tumors. Hence, we examined the therapeutic effect of PTT using a NIR absorbent (ICG lactosome) while changing two parameters (fluence rate and irradiation time) in various combinations. As a result, there was no robust correlation between those parameters and the therapeutic effect. Compared to those parameters, we found that a more reliable determinant was maintenance of the tumor temperature above 43 °C during NIR irradiation. To reconfirm the significance of the determinant, we developed a new system that can regulate the temperature at the NIR irradiation site at a constant level. By using the new system, we verified the treatment outcomes for tumors in which the NIR absorbent had accumulated. All of the tumors that had been kept at 43 °C during NIR irradiation were cured, while none of the tumors that had been kept at a temperature below 41 °C were cured. In conclusion, PTT using a NIR absorbent with thermal dosimetry is a highly reliable treatment for cancer.
doi_str_mv 10.1038/s41598-020-66646-x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7299938</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2414148867</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-a2f706a7fadd6d8173ca754875f6031e4d319bcabd918e85426a8dfe2591b8373</originalsourceid><addsrcrecordid>eNp9kc1u1TAQhS0EolXpC7BAltiS4v_YGyRUQYtUiQ2srUniJK4S-2I70Pv2-HLbUjbYC48135wz0kHoNSUXlHD9PgsqjW4II41SSqjm7hk6ZUTIhnHGnj-pT9B5zrekHsmMoOYlOuFMSsmFOUXbtZ_mZY-TWzx0i3uHC6TJFTfg3RxLLLNLKyy4h9C7hA9f2O1xH9fOhwr98mXGD9AQs19dSXu8ZR8mDDg4SI0PY4JUYehyTJ0L5RV6McKS3fn9e4a-f_707fK6ufl69eXy403Ti1aUBtjYEgXtCMOgBk1b3kMrhW7lqAinTgycmq6HbjBUOy0FU6CH0TFpaKd5y8_Qh6PubutWN_TVOsFid8mvkPY2grf_doKf7RR_2pYZY7iuAm_vBVL8sblc7G3cUqg7WyZovVqrgw07Un2KOSc3PjpQYg9p2WNatqZl_6Rl7-rQm6e7PY48ZFMBfgRybYXJpb_e_5H9DRfKpBE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2414148867</pqid></control><display><type>article</type><title>Highly reliable, targeted photothermal cancer therapy combined with thermal dosimetry using a near-infrared absorbent</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Springer Nature OA Free Journals</source><source>Nature Free</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Nomura, Shinsuke ; Morimoto, Yuji ; Tsujimoto, Hironori ; Arake, Masashi ; Harada, Manabu ; Saitoh, Daizoh ; Hara, Isao ; Ozeki, Eiichi ; Satoh, Ayano ; Takayama, Eiji ; Hase, Kazuo ; Kishi, Yoji ; Ueno, Hideki</creator><creatorcontrib>Nomura, Shinsuke ; Morimoto, Yuji ; Tsujimoto, Hironori ; Arake, Masashi ; Harada, Manabu ; Saitoh, Daizoh ; Hara, Isao ; Ozeki, Eiichi ; Satoh, Ayano ; Takayama, Eiji ; Hase, Kazuo ; Kishi, Yoji ; Ueno, Hideki</creatorcontrib><description>Photothermal therapy (PTT) using a photo-absorbent in the near-infrared (NIR) region is an effective methodology for local cancer treatment. Before PTT using a NIR absorbent is executed, the operator generally determines the two parameters of fluence rate and irradiation time. However, even if the irradiation parameters are unchanged, the therapeutic effect of PTT is often different for individual tumors. Hence, we examined the therapeutic effect of PTT using a NIR absorbent (ICG lactosome) while changing two parameters (fluence rate and irradiation time) in various combinations. As a result, there was no robust correlation between those parameters and the therapeutic effect. Compared to those parameters, we found that a more reliable determinant was maintenance of the tumor temperature above 43 °C during NIR irradiation. To reconfirm the significance of the determinant, we developed a new system that can regulate the temperature at the NIR irradiation site at a constant level. By using the new system, we verified the treatment outcomes for tumors in which the NIR absorbent had accumulated. All of the tumors that had been kept at 43 °C during NIR irradiation were cured, while none of the tumors that had been kept at a temperature below 41 °C were cured. In conclusion, PTT using a NIR absorbent with thermal dosimetry is a highly reliable treatment for cancer.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-020-66646-x</identifier><identifier>PMID: 32555349</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/57 ; 631/61 ; 631/67 ; 692/4028 ; Absorbents ; Animals ; Apoptosis ; Cancer ; Cancer therapies ; Cell Proliferation ; Colonic Neoplasms - pathology ; Colonic Neoplasms - therapy ; Combined Modality Therapy ; Dosimetry ; Female ; Humanities and Social Sciences ; Humans ; Hyperthermia, Induced - methods ; I.R. radiation ; Indocyanine Green - chemistry ; Infrared Rays ; Irradiation ; Mice ; Mice, Inbred BALB C ; multidisciplinary ; Nanoparticles - administration &amp; dosage ; Nanoparticles - chemistry ; Phototherapy - methods ; Science ; Science (multidisciplinary) ; Tumor Cells, Cultured ; Tumors ; Xenograft Model Antitumor Assays</subject><ispartof>Scientific reports, 2020-06, Vol.10 (1), p.9765, Article 9765</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-a2f706a7fadd6d8173ca754875f6031e4d319bcabd918e85426a8dfe2591b8373</citedby><cites>FETCH-LOGICAL-c474t-a2f706a7fadd6d8173ca754875f6031e4d319bcabd918e85426a8dfe2591b8373</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299938/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299938/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27922,27923,41118,42187,51574,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32555349$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nomura, Shinsuke</creatorcontrib><creatorcontrib>Morimoto, Yuji</creatorcontrib><creatorcontrib>Tsujimoto, Hironori</creatorcontrib><creatorcontrib>Arake, Masashi</creatorcontrib><creatorcontrib>Harada, Manabu</creatorcontrib><creatorcontrib>Saitoh, Daizoh</creatorcontrib><creatorcontrib>Hara, Isao</creatorcontrib><creatorcontrib>Ozeki, Eiichi</creatorcontrib><creatorcontrib>Satoh, Ayano</creatorcontrib><creatorcontrib>Takayama, Eiji</creatorcontrib><creatorcontrib>Hase, Kazuo</creatorcontrib><creatorcontrib>Kishi, Yoji</creatorcontrib><creatorcontrib>Ueno, Hideki</creatorcontrib><title>Highly reliable, targeted photothermal cancer therapy combined with thermal dosimetry using a near-infrared absorbent</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>Photothermal therapy (PTT) using a photo-absorbent in the near-infrared (NIR) region is an effective methodology for local cancer treatment. Before PTT using a NIR absorbent is executed, the operator generally determines the two parameters of fluence rate and irradiation time. However, even if the irradiation parameters are unchanged, the therapeutic effect of PTT is often different for individual tumors. Hence, we examined the therapeutic effect of PTT using a NIR absorbent (ICG lactosome) while changing two parameters (fluence rate and irradiation time) in various combinations. As a result, there was no robust correlation between those parameters and the therapeutic effect. Compared to those parameters, we found that a more reliable determinant was maintenance of the tumor temperature above 43 °C during NIR irradiation. To reconfirm the significance of the determinant, we developed a new system that can regulate the temperature at the NIR irradiation site at a constant level. By using the new system, we verified the treatment outcomes for tumors in which the NIR absorbent had accumulated. All of the tumors that had been kept at 43 °C during NIR irradiation were cured, while none of the tumors that had been kept at a temperature below 41 °C were cured. In conclusion, PTT using a NIR absorbent with thermal dosimetry is a highly reliable treatment for cancer.</description><subject>631/57</subject><subject>631/61</subject><subject>631/67</subject><subject>692/4028</subject><subject>Absorbents</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Cell Proliferation</subject><subject>Colonic Neoplasms - pathology</subject><subject>Colonic Neoplasms - therapy</subject><subject>Combined Modality Therapy</subject><subject>Dosimetry</subject><subject>Female</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Hyperthermia, Induced - methods</subject><subject>I.R. radiation</subject><subject>Indocyanine Green - chemistry</subject><subject>Infrared Rays</subject><subject>Irradiation</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>multidisciplinary</subject><subject>Nanoparticles - administration &amp; dosage</subject><subject>Nanoparticles - chemistry</subject><subject>Phototherapy - methods</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Tumor Cells, Cultured</subject><subject>Tumors</subject><subject>Xenograft Model Antitumor Assays</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kc1u1TAQhS0EolXpC7BAltiS4v_YGyRUQYtUiQ2srUniJK4S-2I70Pv2-HLbUjbYC48135wz0kHoNSUXlHD9PgsqjW4II41SSqjm7hk6ZUTIhnHGnj-pT9B5zrekHsmMoOYlOuFMSsmFOUXbtZ_mZY-TWzx0i3uHC6TJFTfg3RxLLLNLKyy4h9C7hA9f2O1xH9fOhwr98mXGD9AQs19dSXu8ZR8mDDg4SI0PY4JUYehyTJ0L5RV6McKS3fn9e4a-f_707fK6ufl69eXy403Ti1aUBtjYEgXtCMOgBk1b3kMrhW7lqAinTgycmq6HbjBUOy0FU6CH0TFpaKd5y8_Qh6PubutWN_TVOsFid8mvkPY2grf_doKf7RR_2pYZY7iuAm_vBVL8sblc7G3cUqg7WyZovVqrgw07Un2KOSc3PjpQYg9p2WNatqZl_6Rl7-rQm6e7PY48ZFMBfgRybYXJpb_e_5H9DRfKpBE</recordid><startdate>20200617</startdate><enddate>20200617</enddate><creator>Nomura, Shinsuke</creator><creator>Morimoto, Yuji</creator><creator>Tsujimoto, Hironori</creator><creator>Arake, Masashi</creator><creator>Harada, Manabu</creator><creator>Saitoh, Daizoh</creator><creator>Hara, Isao</creator><creator>Ozeki, Eiichi</creator><creator>Satoh, Ayano</creator><creator>Takayama, Eiji</creator><creator>Hase, Kazuo</creator><creator>Kishi, Yoji</creator><creator>Ueno, Hideki</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>20200617</creationdate><title>Highly reliable, targeted photothermal cancer therapy combined with thermal dosimetry using a near-infrared absorbent</title><author>Nomura, Shinsuke ; Morimoto, Yuji ; Tsujimoto, Hironori ; Arake, Masashi ; Harada, Manabu ; Saitoh, Daizoh ; Hara, Isao ; Ozeki, Eiichi ; Satoh, Ayano ; Takayama, Eiji ; Hase, Kazuo ; Kishi, Yoji ; Ueno, Hideki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-a2f706a7fadd6d8173ca754875f6031e4d319bcabd918e85426a8dfe2591b8373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>631/57</topic><topic>631/61</topic><topic>631/67</topic><topic>692/4028</topic><topic>Absorbents</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Cell Proliferation</topic><topic>Colonic Neoplasms - pathology</topic><topic>Colonic Neoplasms - therapy</topic><topic>Combined Modality Therapy</topic><topic>Dosimetry</topic><topic>Female</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Hyperthermia, Induced - methods</topic><topic>I.R. radiation</topic><topic>Indocyanine Green - chemistry</topic><topic>Infrared Rays</topic><topic>Irradiation</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>multidisciplinary</topic><topic>Nanoparticles - administration &amp; dosage</topic><topic>Nanoparticles - chemistry</topic><topic>Phototherapy - methods</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Tumor Cells, Cultured</topic><topic>Tumors</topic><topic>Xenograft Model Antitumor Assays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nomura, Shinsuke</creatorcontrib><creatorcontrib>Morimoto, Yuji</creatorcontrib><creatorcontrib>Tsujimoto, Hironori</creatorcontrib><creatorcontrib>Arake, Masashi</creatorcontrib><creatorcontrib>Harada, Manabu</creatorcontrib><creatorcontrib>Saitoh, Daizoh</creatorcontrib><creatorcontrib>Hara, Isao</creatorcontrib><creatorcontrib>Ozeki, Eiichi</creatorcontrib><creatorcontrib>Satoh, Ayano</creatorcontrib><creatorcontrib>Takayama, Eiji</creatorcontrib><creatorcontrib>Hase, Kazuo</creatorcontrib><creatorcontrib>Kishi, Yoji</creatorcontrib><creatorcontrib>Ueno, Hideki</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database (ProQuest)</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nomura, Shinsuke</au><au>Morimoto, Yuji</au><au>Tsujimoto, Hironori</au><au>Arake, Masashi</au><au>Harada, Manabu</au><au>Saitoh, Daizoh</au><au>Hara, Isao</au><au>Ozeki, Eiichi</au><au>Satoh, Ayano</au><au>Takayama, Eiji</au><au>Hase, Kazuo</au><au>Kishi, Yoji</au><au>Ueno, Hideki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Highly reliable, targeted photothermal cancer therapy combined with thermal dosimetry using a near-infrared absorbent</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2020-06-17</date><risdate>2020</risdate><volume>10</volume><issue>1</issue><spage>9765</spage><pages>9765-</pages><artnum>9765</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Photothermal therapy (PTT) using a photo-absorbent in the near-infrared (NIR) region is an effective methodology for local cancer treatment. Before PTT using a NIR absorbent is executed, the operator generally determines the two parameters of fluence rate and irradiation time. However, even if the irradiation parameters are unchanged, the therapeutic effect of PTT is often different for individual tumors. Hence, we examined the therapeutic effect of PTT using a NIR absorbent (ICG lactosome) while changing two parameters (fluence rate and irradiation time) in various combinations. As a result, there was no robust correlation between those parameters and the therapeutic effect. Compared to those parameters, we found that a more reliable determinant was maintenance of the tumor temperature above 43 °C during NIR irradiation. To reconfirm the significance of the determinant, we developed a new system that can regulate the temperature at the NIR irradiation site at a constant level. By using the new system, we verified the treatment outcomes for tumors in which the NIR absorbent had accumulated. All of the tumors that had been kept at 43 °C during NIR irradiation were cured, while none of the tumors that had been kept at a temperature below 41 °C were cured. In conclusion, PTT using a NIR absorbent with thermal dosimetry is a highly reliable treatment for cancer.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>32555349</pmid><doi>10.1038/s41598-020-66646-x</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2045-2322
ispartof Scientific reports, 2020-06, Vol.10 (1), p.9765, Article 9765
issn 2045-2322
2045-2322
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7299938
source MEDLINE; DOAJ Directory of Open Access Journals; Springer Nature OA Free Journals; Nature Free; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects 631/57
631/61
631/67
692/4028
Absorbents
Animals
Apoptosis
Cancer
Cancer therapies
Cell Proliferation
Colonic Neoplasms - pathology
Colonic Neoplasms - therapy
Combined Modality Therapy
Dosimetry
Female
Humanities and Social Sciences
Humans
Hyperthermia, Induced - methods
I.R. radiation
Indocyanine Green - chemistry
Infrared Rays
Irradiation
Mice
Mice, Inbred BALB C
multidisciplinary
Nanoparticles - administration & dosage
Nanoparticles - chemistry
Phototherapy - methods
Science
Science (multidisciplinary)
Tumor Cells, Cultured
Tumors
Xenograft Model Antitumor Assays
title Highly reliable, targeted photothermal cancer therapy combined with thermal dosimetry using a near-infrared absorbent
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T14%3A48%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Highly%20reliable,%20targeted%20photothermal%20cancer%20therapy%20combined%20with%20thermal%20dosimetry%20using%20a%20near-infrared%20absorbent&rft.jtitle=Scientific%20reports&rft.au=Nomura,%20Shinsuke&rft.date=2020-06-17&rft.volume=10&rft.issue=1&rft.spage=9765&rft.pages=9765-&rft.artnum=9765&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-020-66646-x&rft_dat=%3Cproquest_pubme%3E2414148867%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2414148867&rft_id=info:pmid/32555349&rfr_iscdi=true